Your search for comorbidities returned 243 results

A study was conducted to assess the effect of sarcopenia and cachexia on clinical outcomes in older patients with heart failure.

Researchers compared different factors among US veterans with and without carbapenemase-producing carbapenem-resistant Enterobacterales cultures.

Study finds genuine difference between a fixed-dose combination of isosorbide dinitrate plus hydralazine HCl and an off-label combination of the separate generic drugs for the treatment of heart failure in African American patients.

Researchers sought to investigate the 30-day readmission rate (30-DRr) for acute congestive HF (aCHF) in patients with co-existing MetS, the outcomes, and health care consumption.

Using a cohort of Medicare beneficiaries, researchers sought to determine the association between nonalcoholic fatty liver disease and heart failure.

Current practices for symptom management may not adequately address nontraditional HF symptoms including anxiety, depression, and pain.

Occurrence of new-onset AF in the month following AMI was found to be associated with elevated risks for death and ischemic stroke.

Investigators sought to determine whether galectin-3 may effectively predict mortality and heart failure after a myocardial infarction.

Consumption of 7 or fewer drinks per week was associated with significantly longer survival following the diagnosis of heart failure compared with abstinence.

Out 952 patients, 20 experienced sudden cardiac death/malignant ventricular arrhythmias within the first 6 months of the study enrollment.